Metabolic and Proteomic Profiles Associated with Immune Responses Induced by Different Inactivated SARS-CoV-2 Vaccine

Shouzhi Yu1, Yao He1, Wenheng Ji1

  • 1Beijing Institute of Biological Products Company Limited, Beijing 100176, China.

Insights

Different inactivated SARS-CoV-2 vaccines targeting the prototype, Delta, and Omicron variants induced strong immune responses in mice. Variations in vaccine strains altered protein and metabolic profiles, offering insights for future vaccine design.

Area of Science:

  • Immunology
  • Virology
  • Metabolomics
  • Proteomics

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continuously mutates, leading to new variants and challenges in epidemic control.
  • Understanding the impact of these variants on vaccine efficacy is crucial.

Purpose of the Study:

  • To investigate the immune, protein, and metabolomic changes induced by inactivated SARS-CoV-2 vaccines composed of different variants.
  • To explore how amino acid variations in SARS-CoV-2 strains affect host responses.

Main Methods:

  • Mice were immunized with inactivated vaccine candidates based on the prototype strain and Delta and Omicron variants.
  • Immune responses, including neutralizing antibodies and cellular immunity, were assessed.
  • Metabolomic and proteomic profiling was performed to analyze systemic changes.

Main Results:

  • All tested inactivated vaccine candidates (prototype, Delta, Omicron) successfully induced high levels of neutralizing antibodies and cellular immunity in mice.
  • Significant alterations in metabolic and protein profiles were observed post-vaccination.
  • The extent of these metabolic and proteomic changes positively correlated with immune responses and varied distinctly among different vaccine variants, suggesting an impact of amino acid variations.

Conclusions:

  • Inactivated SARS-CoV-2 vaccines targeting different variants elicit comparable robust immune responses but induce distinct metabolomic and proteomic profiles.
  • Amino acid variations within SARS-CoV-2 strains influence host metabolomic and proteomic landscapes.
  • These findings offer novel insights for vaccine immune evaluation and can guide future vaccine design strategies.

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.5K
Vaccinations01:51

Vaccinations

Overview
45.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
886
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.7K